IO Biotech Inc (IOBT)

1.76 +0.16 (+10.00%)
Close USD Disclaimer
1.75 -0.01 (-0.57%)

IO Biotech Inc Company Profile

Equity Type
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
Contact Information
Copenhagen,2200 Denmark
45 70 70 29 80
Top Executives
Kathleen Sereda Glaub 68 2018 Independent Director
Peter K. Hirth 70 2016 Independent Chairman
Inge Marie Svane 0 0000 Founder & Clinical Advisor
Mads Hald Andersen 0 0000 Founder & Scientific Advisor
Alexander Maximiliaan Marie Eggermont 0 0000 Sr. Clinical Advisor & Member of the Scientific Advisory Board
David V. Smith 63 2022 Independent Director
Kapil Dhingra 64 0000 Strategic Advisory Board Member
Christian E. Elling 53 2015 Independent Director
Jack Beck Nielsen 59 2021 Independent Director
Heidi Hunter 65 2023 Director
Helen Louise Collins 60 2023 Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles